Nanoagents of integrating multiple imaging and therapeutic modalities have attracted tremendous attention for biomedical applications. Herein, we synthesize porous hollow Fe3O4 as a theranostic agent for MRI and combined photothermal/chemo cancer therapy. The as-prepared porous iron oxide nanoagents allow for T2-weighted MR imaging. Interestingly, we demonstrate that the porous structure endows the nanoagents an outstanding photothermal property for cancer cell killing, in comparison with other types of iron oxide nanomaterials. Under the exposure of an NIR laser, the heat produced by porous Fe3O4 can accelerate the release of the loaded drug (e.g., DOX) to enhance chemotherapeutic efficacy, promoting the ablation of cancer cells with synergistic photothermal/chemotherapy.
Keyphrases
- cancer therapy
- iron oxide
- drug delivery
- metal organic framework
- contrast enhanced
- photodynamic therapy
- magnetic resonance imaging
- highly efficient
- tissue engineering
- drug release
- magnetic resonance
- high resolution
- squamous cell carcinoma
- diffusion weighted imaging
- computed tomography
- working memory
- cell therapy
- atrial fibrillation
- adverse drug
- liquid chromatography
- smoking cessation